New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Merck & Co., Inc.

MRK

Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024.

Revenue
+4.68%
EPS
−12.1%
Free cash flow
−19.3%
Total debt
+24.3%

Quarter to September 2026, against a year earlier

134.64 1.90 +1.43%
Market cap
$328.6B
P/E
137×
Fwd P/E FY26e
105×
Dividend yield
2.56%
F-score
4/9
ROIC
4.56%
Net debt / EBITDA
1.2×
Payout ratio
3.5×

Revenue to profit Q3 FY2026, quarter to Sep 30, 2026

Of every $100 of revenue, $28.02 was left as profit. Gross margin has fallen two quarters running, from 74.2% to 72.9%. What is an income statement?

Revenue to profit, in billions of dollars and as a share of revenue
Revenue18.1100.0%
Cost of revenue−4.9−27.1%
Gross profit13.272.9%
Research & development−4.5−25.1%
Selling, general & admin−2.9−16.0%
Operating income5.831.9%
Other income, net−0.2−1.2%
Income tax−0.5−2.7%
Net income5.128.0%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue$16.4B$16.3B$16.6B$18.1B
Operating income$4.1B−$3.2B−$433M$5.8B
Net income$3.0B−$4.2B−$1.3B$5.1B
Net margin (right axis)18.1%−26.1%−8.1%28.0%
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Revenue
18,085.00 16,607.00 16,286.00 16,400.00

+8 more quarters

Revenue Growth
4.68% 5.07% 4.87% 4.97%
Gross Profit
13,193.00 12,212.00 12,091.00 10,849.00
Operating Income
5,770.00 (433.00) (3,201.00) 4,064.00
EBT
5,559.00 (683.00) (3,534.00) 3,420.00
Income after Tax
5,067.00 (1,337.00) (4,243.00) 2,963.00
Net Income Common
5,065.00 (1,335.00) (4,240.00) 2,963.00
EPS (Diluted)
2.04 (0.54) (1.72) 1.19
Shares (Diluted, Weighted)
2,478.00 2,470.00 2,472.00 2,507.00
Gross Margin
72.95% 73.54% 74.24% 66.15%
EBIT Margin
31.90% (2.61%) (19.65%) 24.78%
Net Profit Margin
28.01% (8.04%) (26.03%) 18.07%
EBITDA
7,553.00 1,150.00 (1,689.00) 6,530.00
EBIT
5,770.00 (433.00) (3,201.00) 4,064.00

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026